Anti-HIV medications have the potential to suppress the viral load of people living with HIV and provide durable protection against heterosexual transmission, a study says.
The findings showed that a 93 per cent reduction of HIV transmission occurred when the HIV-infected person started antiretroviral therapy or ART at a higher CD4 cell count -- a marker of good immune system health.
"The study confirms the urgent need to treat people with HIV infection as soon as the infection is diagnosed to protect their health and for public health," said lead author Myron S. Cohen from University of North Carolina in the US.
The results have helped to galvanise a worldwide commitment to a universal "treatment as prevention" strategy for combating the HIV/AIDS epidemic, with ART offered to all HIV-infected people, regardless of CD4 cell count, said the paper published in the New England Journal of Medicine.
For the study, which began in 2005, the team enrolled 1,763 HIV-serodiscordant couples -- where one person was living with HIV and the other was not - at 13 sites in nine countries including India (Botswana, Brazil, Kenya, Malawi, South Africa, Thailand, the US and Zimbabwe).
Ninety-seven per cent of the couples were heterosexual. HIV-infected participants were assigned at random to start ART at the beginning of the study when their immune system was relatively healthy (called the "early" arm), or later in the study when they had immune system decline (called the "delayed" arm).
--IANS
rt/ask/vm
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
